Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Philip Hemme,  Interviewing Anker Lundemose in Zurich @ 9th Annual Sachs conference for European Biotech CEOs

Reporter: Aviva Lev-Ari, PhD, RN

Philip Hemme, Co-Founder & CEO of Labiotech.eu

Anker Lundemose, CEO of Mission Therapeutics, from just outside of Cambridge (UK). Founded in 2011, Mission Therapeutics, a private drug discovery company which aims to commercialize highly expert research towards the treatment of cancer and other diseases via the ubiquitin cell signaling pathway.

WATCH VIDEO

http://labiotech.eu/interviewing-the-biotech-which-raised-the-biggest-european-round-in-2016-so-far/

SOURCE

http://labiotech.eu/interviewing-the-biotech-which-raised-the-biggest-european-round-in-2016-so-far/

Other related articles published on this Open Access Online Scientific Journal include the following:

14th ANNUAL BIOTECH IN EUROPE FORUM For Global Partnering & Investment
30th September – 1st October 2014 • Congress Center Basel
SACHS Associates, London
http://www.sachsforum.com/zurich14/index.html

http://pharmaceuticalintelligence.com/2014/03/25/14th-annual-biotech-in-europe-forum-for-global-partnering-investment-930-1012014-•-congress-center-basel-sachs-associates-london/

The 2nd ANNUAL Sachs Cancer Bio Partnering & Investment Forum in Drug Development, 19th March 2014 • New York Academy of Sciences • USA
http://pharmaceuticalintelligence.com/2014/03/21/real-time-cancer-conference-coverage-a-novel-methodology-for-authentic-reporting-on-presentations-and-discussions-launched-via-twitter-com-the-2nd-annual-sachs-cancer-bio-partnering-investmen/